Literature DB >> 29238875

Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis.

Jing Wang1, Yu Zhao2, Jianjun Ren1, Yang Xu1.   

Abstract

OBJECTIVE: Pepsin in saliva has been proposed as a biomarker for the diagnosis of laryngopharyngeal reflux (LPR), but the results remain controversial. We assessed the diagnostic value of pepsin in saliva for LPR.
METHODS: PubMed, Embase, and Web of Science were searched for studies in English that evaluated the utility of pepsin in saliva in the diagnosis of LPR, published up to 15 March 2017. We used Stata 12.0 to summarize the diagnostic indexes for the meta-analysis.
RESULTS: Eleven eligible studies met the inclusion criteria. After the meta-analysis of included studies, the pooled sensitivity and specificity were 64% [95% confidence interval (CI) 43-80%] and 68% (95% CI 55-78%), respectively; the positive (PLR) and negative (NLR) likelihood ratios were 2.0 (95% CI 1.4-2.9) and 0.54 (95% CI 0.33-0.87), respectively; the diagnostic odds ratio (DOR) was 4 (95% CI 2-8); and the area under the curve (AUC) was 0.71 (95% CI 0.67-0.75).
CONCLUSION: Pepsin in saliva has moderate value in the diagnosis of LPR. The cutoff value used could affect the diagnostic value. Therefore, further investigations are required to find the optimal method to detect salivary pepsin in diagnosing LPR.

Keywords:  Diagnostic value; Laryngopharyngeal reflux; Meta-analysis; Pepsin; Sensitivity; Specificity

Mesh:

Substances:

Year:  2017        PMID: 29238875     DOI: 10.1007/s00405-017-4845-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Shih-Kuang S Hong; Vicki Strugala; James C Slaughter; Marion Goutte; C Gaelyn Garrett; Peter W Dettmar; Michael F Vaezi
Journal:  Laryngoscope       Date:  2012-03-23       Impact factor: 3.325

2.  Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux.

Authors:  Emre Ocak; Gözde Kubat; İrfan Yorulmaz
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

3.  Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux.

Authors:  S I Kim; O E Kwon; S Y Na; Y C Lee; J M Park; Y G Eun
Journal:  Clin Otolaryngol       Date:  2017-01-08       Impact factor: 2.597

Review 4.  Pepsin as a marker of extraesophageal reflux.

Authors:  Tina L Samuels; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-03       Impact factor: 1.547

5.  Experimental study for the mechanism of gastroesophageal-reflux-associated asthma.

Authors:  G-C Zhu; Xiang Gao; Z-G Wang; Z-W Hu; C-C Zhang; Y-G Lai; F Ji; J-M Wu
Journal:  Dis Esophagus       Date:  2013-09-05       Impact factor: 3.429

6.  Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.

Authors:  Fei Dy; Janine Amirault; Paul D Mitchell; Rachel Rosen
Journal:  J Pediatr       Date:  2016-07-21       Impact factor: 4.406

7.  Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung.

Authors:  Sunitha Potluri; Frank Friedenberg; Henry P Parkman; Alan Chang; Robert MacNeal; Christopher Manus; Matthew Q Bromer; Aslam Malik; Robert S Fisher; Thomas Nugent; Vinod K Thangada; Friedrich Kueppers; Larry S Miller
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency.

Authors:  Samantha Decalmer; Rachel Stovold; Lesley A Houghton; Jeff Pearson; Chris Ward; Angela Kelsall; Helen Jones; Kevin McGuinness; Ashley Woodcock; Jaclyn A Smith
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

9.  Investigation of pepsin in tears of children with laryngopharyngeal reflux disease.

Authors:  Giannicola Iannella; Giovanni Di Nardo; Rocco Plateroti; Paolo Rossi; Andrea Maria Plateroti; Paola Mariani; Giuseppe Magliulo
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2015-10-30       Impact factor: 1.675

10.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

View more
  14 in total

Review 1.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

2.  ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.

Authors:  C Prakash Gyawali; Dustin A Carlson; Joan W Chen; Amit Patel; Robert J Wong; Rena H Yadlapati
Journal:  Am J Gastroenterol       Date:  2020-09       Impact factor: 12.045

3.  Influence of proton pump inhibitor therapy on occurrence of voice prosthesis complications.

Authors:  Ana Danic Hadzibegovic; Ana Kozmar; Irzal Hadzibegovic; Drago Prgomet; Davorin Danic
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-17       Impact factor: 2.503

4.  Reflux characteristics in patients with gastroesophageal reflux-related chronic cough complicated by laryngopharyngeal reflux.

Authors:  Yiming Yu; Siwan Wen; Shengyuan Wang; Cuiqin Shi; Hongmei Ding; Zhongmin Qiu; Xianghuai Xu; Li Yu
Journal:  Ann Transl Med       Date:  2019-10

5.  Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Authors:  Yong Feng Wang; Chang Qing Yang; Ying Xuan Chen; Ai Ping Cao; Xiao Feng Yu; Yang Yu; Zi Yan Zhang; Xi Zhong Shen; Fei Liu; Lan Zhong; Ying Xin Wang; Zhan Ju Liu; Yan Hong Shi; Jie Zhong; Jing Nan Li; Yu Lan; Rhianna K Lenham; Andrew D Woodcock; Peter W Dettmar; Jing-Yuan Fang
Journal:  J Dig Dis       Date:  2019-06       Impact factor: 2.325

Review 6.  Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.

Authors:  Jerome R Lechien; Sven Saussez; Vinciane Muls; Maria R Barillari; Carlos M Chiesa-Estomba; Stéphane Hans; Petros D Karkos
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

7.  The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.

Authors:  Zihao Guo; Yanhong Wu; Jing Chen; Shutian Zhang; Chuan Zhang
Journal:  Med Sci Monit       Date:  2020-11-21

8.  Evidence of Pepsin-Related Ocular Surface Damage and Dry Eye (PROD Syndrome) in Patients with Laryngopharyngeal Reflux.

Authors:  Rocco Plateroti; Marta Sacchetti; Giuseppe Magliulo; Andrea Maria Plateroti; Annalisa Pace; Antonietta Moramarco; Alessandro Lambiase; Alice Bruscolini
Journal:  Life (Basel)       Date:  2020-09-15

9.  Laryngopharyngeal Reflux: Symptoms, Signs, and Presence of Pepsin in Saliva - A Reliable Diagnostic Triad.

Authors:  Shilpa Divakaran; Sivaa Rajendran; Roshan Marie Thomas; Jaise Jacob; Mary Kurien
Journal:  Int Arch Otorhinolaryngol       Date:  2020-06-30

10.  Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Authors:  Yan-Jun Wang; Xiu-Qiong Lang; Dan Wu; Yu-Qin He; Chun-Hui Lan; Xiao Xiao; Bin Wang; Duo-Wu Zou; Ji-Min Wu; Yong-Bin Zhao; Peter W Dettmar; Dong-Feng Chen; Min Yang
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.